Aspen Aerogels (NYSE:ASPN) Stock Rating Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Aspen Aerogels (NYSE:ASPN) from a sell rating to a hold rating in a report released on Saturday,Wall Street Zen reports.

A number of other research firms also recently commented on ASPN. B. Riley Financial reissued a “buy” rating on shares of Aspen Aerogels in a report on Friday, August 7th. Barclays increased their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Tuesday, August 11th. Roth Capital reiterated a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research report on Friday, August 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, September 21st. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.94.

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $5.06 on Friday. Aspen Aerogels has a one year low of $2.30 and a one year high of $8.56. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52. The business has a fifty day moving average of $5.25 and a two-hundred day moving average of $4.67. The company has a market cap of $419.93 million, a P/E ratio of -3.31 and a beta of 3.06.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The company had revenue of $49.85 million for the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, analysts predict that Aspen Aerogels will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of the firm’s stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total value of $58,086,414.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 2.96% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in Aspen Aerogels during the second quarter worth about $33,457,000. Oaktop Capital Management II L.P. purchased a new stake in shares of Aspen Aerogels in the second quarter valued at about $32,769,000. George Kaiser Family Foundation purchased a new stake in shares of Aspen Aerogels in the second quarter valued at about $20,081,000. Rice Hall James & Associates LLC purchased a new stake in shares of Aspen Aerogels in the second quarter valued at about $10,368,000. Finally, Deutsche Bank AG acquired a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $2,359,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.

Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.